Calimano-Ramirez L, Virarkar M, Hernandez M, Ozdemir S, Kumar S, Gopireddy D
Abdom Radiol (NY). 2023; 48(7):2379-2400.
PMID: 37142824
DOI: 10.1007/s00261-023-03924-y.
Li H, Lee C, Chia D, Lin Z, Huang W, Tan C
Diagnostics (Basel). 2022; 12(2).
PMID: 35204380
PMC: 8870978.
DOI: 10.3390/diagnostics12020289.
Xu L, Zhang G, Zhang X, Bai X, Yan W, Xiao Y
Front Oncol. 2021; 11:655093.
PMID: 33869062
PMC: 8047629.
DOI: 10.3389/fonc.2021.655093.
Gupta R, Mahajan M, Sharma P
Int J Appl Basic Med Res. 2021; 11(1):32-35.
PMID: 33842293
PMC: 8025949.
DOI: 10.4103/ijabmr.IJABMR_115_20.
Xu L, Zhang G, Zhao L, Mao L, Li X, Yan W
Front Oncol. 2020; 10:940.
PMID: 32612953
PMC: 7308458.
DOI: 10.3389/fonc.2020.00940.
Radiological semantics discriminate clinically significant grade prostate cancer.
Li Q, Lu H, Choi J, Gage K, Feuerlein S, Pow-Sang J
Cancer Imaging. 2019; 19(1):81.
PMID: 31796094
PMC: 6889697.
DOI: 10.1186/s40644-019-0272-y.
Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.
Dominguez C, Plata M, Catano J, Palau M, Aguirre D, Narvaez J
Int Braz J Urol. 2018; 44(4):688-696.
PMID: 29570254
PMC: 6092654.
DOI: 10.1590/S1677-5538.IBJU.2016.0485.
Value of three-dimensional T2-weighted turbo spin-echo imaging with tissue-specific variable refocusing flip angle for 3-T magnetic resonance imaging of prostate cancer: comparison with conventional two- and three-dimensional T2-weighted turbo....
Tanaka U, Ueno Y, Morinaga Y, Miyake H, Kyotani K, Ueda Y
Jpn J Radiol. 2017; 35(12):707-717.
PMID: 28983811
DOI: 10.1007/s11604-017-0684-1.
Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.
Rosenkrantz A, Ginocchio L, Cornfeld D, Froemming A, Gupta R, Turkbey B
Radiology. 2016; 280(3):793-804.
PMID: 27035179
PMC: 5006735.
DOI: 10.1148/radiol.2016152542.
Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use.
Barentsz J, Weinreb J, Verma S, Thoeny H, Tempany C, Shtern F
Eur Urol. 2015; 69(1):41-9.
PMID: 26361169
PMC: 6364687.
DOI: 10.1016/j.eururo.2015.08.038.
Evaluation of Multiparametric Magnetic Resonance Imaging in Detection and Prediction of Prostate Cancer.
Wang R, Wang H, Zhao C, Hu J, Jiang Y, Tong Y
PLoS One. 2015; 10(6):e0130207.
PMID: 26067423
PMC: 4466371.
DOI: 10.1371/journal.pone.0130207.
Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology.
Boesen L, Chabanova E, Logager V, Balslev I, Mikines K, Thomsen H
Eur Radiol. 2014; 25(6):1776-85.
PMID: 25504428
DOI: 10.1007/s00330-014-3543-9.
Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice.
Billing A, Buchner A, Stief C, Roosen A
World J Urol. 2014; 33(7):923-8.
PMID: 25432525
DOI: 10.1007/s00345-014-1448-5.
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.
Muller B, Futterer J, Gupta R, Katz A, Kirkham A, Kurhanewicz J
BJU Int. 2013; 113(2):218-27.
PMID: 24215670
PMC: 4131409.
DOI: 10.1111/bju.12243.
Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.
Bratan F, Niaf E, Melodelima C, Chesnais A, Souchon R, Mege-Lechevallier F
Eur Radiol. 2013; 23(7):2019-29.
PMID: 23494494
DOI: 10.1007/s00330-013-2795-0.
Contrast-enhanced ultrasound as support for prostate brachytherapy treatment planning.
Pieters B, Wijkstra H, Van Herk M, Kuipers R, Kaljouw E, de la Rosette J
J Contemp Brachytherapy. 2013; 4(2):69-74.
PMID: 23349647
PMC: 3552627.
DOI: 10.5114/jcb.2012.29362.
Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance.
Hole K, Axcrona K, Lie A, Vlatkovic L, Geier O, Brennhovd B
Eur Radiol. 2012; 23(4):1158-66.
PMID: 23114883
PMC: 3599204.
DOI: 10.1007/s00330-012-2669-x.
Prostate focused ultrasound focal therapy--imaging for the future.
Rouviere O, Gelet A, Crouzet S, Chapelon J
Nat Rev Clin Oncol. 2012; 9(12):721-7.
PMID: 22910682
DOI: 10.1038/nrclinonc.2012.136.
Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.
Pugh T, Frank S, Achim M, Kuban D, Lee A, Hoffman K
Brachytherapy. 2012; 12(3):204-9.
PMID: 22673704
PMC: 4158734.
DOI: 10.1016/j.brachy.2011.12.013.
Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI?.
Rouviere O, Papillard M, Girouin N, Boutier R, Rabilloud M, Riche B
Eur Radiol. 2012; 22(5):1149-57.
PMID: 22227613
DOI: 10.1007/s00330-011-2343-8.
